Amir Snapir

2.8k total citations · 1 hit paper
39 papers, 1.9k citations indexed

About

Amir Snapir is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Amir Snapir has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in Amir Snapir's work include Prostate Cancer Treatment and Research (13 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Receptor Mechanisms and Signaling (7 papers). Amir Snapir is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Radiopharmaceutical Chemistry and Applications (8 papers) and Receptor Mechanisms and Signaling (7 papers). Amir Snapir collaborates with scholars based in Finland, United States and France. Amir Snapir's co-authors include Mika Scheinin, Karim Fizazi, Teuvo L.J. Tammela, Egils Vjaters, Toni Sarapohja, Neal D. Shore, Iris Kuss, Mindaugas Jievaltas, Albertas Ulys and B. Yа. Alekseev and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Amir Snapir

39 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

2019 579 citations Karim Fizazi, Neal D. Shore et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amir Snapir Finland	18	932	367	332	326	315	39	1.9k
Michael W. Manning United States	17	1.2k 1.3×	267 0.7×	103 0.3×	45 0.1×	162 0.5×	42	2.5k
Juha Koskenvuo Finland	25	288 0.3×	515 1.4×	129 0.4×	340 1.0×	45 0.1×	93	2.0k
Franz Kehl Germany	26	140 0.2×	229 0.6×	262 0.8×	145 0.4×	38 0.1×	60	1.8k
John Butterworth United States	19	91 0.1×	329 0.9×	173 0.5×	92 0.3×	44 0.1×	47	1.4k
Corina Andresen United States	12	143 0.2×	147 0.4×	1.8k 5.4×	145 0.4×	33 0.1×	26	2.4k
Lili Huang China	13	317 0.3×	254 0.7×	99 0.3×	73 0.2×	141 0.4×	30	923
Kathrin Zaugg Switzerland	22	325 0.3×	771 2.1×	27 0.1×	200 0.6×	287 0.9×	43	1.6k
Ivo W. Tremont‐Lukats United States	15	365 0.4×	192 0.5×	187 0.6×	74 0.2×	72 0.2×	42	1.3k
S Umemura Japan	22	182 0.2×	467 1.3×	39 0.1×	41 0.1×	79 0.3×	86	1.5k
Séréna Grimaldi Italy	20	235 0.3×	649 1.8×	33 0.1×	280 0.9×	260 0.8×	49	1.9k

Countries citing papers authored by Amir Snapir

Since Specialization

Citations

This map shows the geographic impact of Amir Snapir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Snapir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Snapir more than expected).

Fields of papers citing papers by Amir Snapir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Snapir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Snapir. The network helps show where Amir Snapir may publish in the future.

Co-authorship network of co-authors of Amir Snapir

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Snapir. A scholar is included among the top collaborators of Amir Snapir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Snapir. Amir Snapir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fizazi, Karim, Neal D. Shore, Teuvo L.J. Tammela, et al.. (2020). 223P Overall survival (OS) results of phase III ARAMIS study of darolutamide (DARO) added to androgen deprivation therapy (ADT) for non-metastatic castration-resistant prostate cancer (nmCRPC). Annals of Oncology. 31. S1328–S1328. 2 indexed citations

Massard, Christophe, Heidi Penttinen, Egils Vjaters, et al.. (2015). Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 Study. European Urology. 69(5). 834–840. 48 indexed citations

Herrick, Ariane L., Andrea Murray, Juha Rouru, et al.. (2014). A double-blind, randomized, placebo-controlled crossover trial of the 2C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis. Lara D. Veeken. 53(5). 948–952. 26 indexed citations

Posti, Jussi P., Perttu Salo, Saku Ruohonen, et al.. (2013). A polymorphism in the protein kinase C gene PRKCB is associated with α2-adrenoceptor-mediated vasoconstriction. Pharmacogenetics and Genomics. 23(3). 127–134. 4 indexed citations

Warner, Amelia, et al.. (2011). Current Practices for DNA Sample Collection and Storage in the Pharmaceutical Industry, and Potential Areas for Harmonization: Perspective of the I-PWG. Clinical Pharmacology & Therapeutics. 89(4). 546–553. 7 indexed citations

Warner, Amelia, Anahita Bhathena, Diane U. Leong, et al.. (2011). Challenges in Obtaining Adequate Genetic Sample Sets in Clinical Trials: The Perspective of the Industry Pharmacogenomics Working Group. Clinical Pharmacology & Therapeutics. 89(4). 529–536. 15 indexed citations

Ricci, Deborah, et al.. (2011). Global Requirements for DNA Sample Collections: Results of a Survey of 204 Ethics Committees in 40 Countries. Clinical Pharmacology & Therapeutics. 89(4). 554–561. 11 indexed citations

Cohen, Nadine, et al.. (2011). Coding of DNA Samples and Data in the Pharmaceutical Industry: Current Practices and Future Directions—Perspective of the I-PWG. Clinical Pharmacology & Therapeutics. 89(4). 537–545. 6 indexed citations

Posti, Jussi P., et al.. (2010). Dorsal hand vein responses to the α1-adrenoceptor agonist phenylephrine do not predict responses to the α2-adrenoceptor agonist dexmedetomidine. European Journal of Pharmacology. 653(1-3). 70–74. 5 indexed citations

10.

Blaise, Régis, et al.. (2009). Identification of a novel 12-nucleotide insertion polymorphism in the promoter region of ADRA2B: Full linkage with the 9-nucleotide deletion in the coding region and influence on transcriptional activity. Biochemical Pharmacology. 79(3). 407–412. 7 indexed citations

11.

Bromley, Christina M., Sandra Close, Nadine Cohen, et al.. (2008). Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group. The Pharmacogenomics Journal. 9(1). 14–22. 14 indexed citations

12.

Snapir, Amir, Pekka Talke, Jussi P. Posti, et al.. (2008). Effects of nitric oxide synthase inhibition on dexmedetomidine-induced vasoconstriction in healthy human volunteers. British Journal of Anaesthesia. 102(1). 38–46. 31 indexed citations

13.

Huupponen, Eero, Mika Särkelä, A. Saastamoinen, et al.. (2007). Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleep. Acta Anaesthesiologica Scandinavica. 52(2). 289–294. 227 indexed citations

14.

Snapir, Amir, Jussi P. Posti, Erkki Kentala, et al.. (2006). Effects of Low and High Plasma Concentrations of Dexmedetomidine on Myocardial Perfusion and Cardiac Function in Healthy Male Subjects. Anesthesiology. 105(5). 902–910. 102 indexed citations

15.

Penttilä, Jani, Amir Snapir, Erkki Kentala, et al.. (2006). Estimation of cardiac output in a pharmacological trial using a simple method based on arterial blood pressure signal waveform: a comparison with pulmonary thermodilution and echocardiographic methods. European Journal of Clinical Pharmacology. 62(6). 401–407. 17 indexed citations

16.

Kiviniemi, Tuomas, Amir Snapir, Markku Saraste, et al.. (2006). Determinants of coronary flow velocity reserve in healthy young men. American Journal of Physiology-Heart and Circulatory Physiology. 291(2). H564–H569. 17 indexed citations

17.

Talke, Pekka, et al.. (2005). Alpha-2B adrenoceptor polymorphism and peripheral vasoconstriction. Pharmacogenetics and Genomics. 15(5). 357–363. 15 indexed citations

18.

Snapir, Amir, Mika Scheinin, Leif Groop, & Marju Orho‐Melander. (2003). The insertion/deletion variation in the α2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes. Cardiovascular Diabetology. 2(1). 15–15. 10 indexed citations

19.

Cayla, Cécile, Paula Heinonen, Stéphane Schaak, et al.. (2003). Cloning, characterisation and identification of several polymorphisms in the promoter region of the human α2B-adrenergic receptor gene. Biochemical Pharmacology. 67(3). 469–478. 12 indexed citations

20.

Snapir, Amir, Paula Heinonen, Tomi‐Pekka Tuomainen, et al.. (2001). An insertion/deletion polymorphism in the α2b-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. Journal of the American College of Cardiology. 37(6). 1516–1522. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact